Bio-Reference – BRLI – Announces InCellDx Investment
Bio-Reference Laboratories, Inc. (NASDAQ: BRLI) announced that it has completed an equity investment in InCellDx, Inc. , a privately held molecular diagnostics start-up company dedicated to the detection and monitoring of life -threatening diseases...